Poop pills could save lives after stem cell transplants
NCT ID NCT07364617
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether fecal microbiota transplantation (FMT) can help people with severe gut graft-versus-host disease (GvHD) that doesn't respond to steroids. GvHD is a common and dangerous complication after stem cell transplants, where donor cells attack the patient's body. The trial will give FMT to 35 participants to see if it can restore healthy gut bacteria and improve survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital at Linkou
RECRUITINGTaoyuan, 333423, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
- Gene analysis may unlock secrets of bone marrow transplant complication
- Aggressive chemo plus stem cell transplant tested for breast cancer
- Herbal extract shows promise for stiff skin and joints in transplant survivors
- Immune-Guided drug timing could cut CMV prevention after transplant
- New drug shows promise in preventing Graft-Versus-Host disease